-
Body
-
Physical Health
Organon Malaysia: A New Holistic Women’s Health Company
July 16th, 2021 at 3:25 am
Organon (NYSE: OGN) has launched as the only global company of its size focused on women’s health through a holistic lens. Organon in Malaysia will be led by Bilal Somra with a total of 36 employees focusing on the scaled portfolio of contraceptive, fertility, cardiovascular and other trusted legacy brands.
“We are thrilled to embark on this journey in multicultural Malaysia which is home to 15.9 million women from diverse backgrounds and walks of life. Because we believe in a better and healthier every day for every woman, our aim is to be a close partner to women in Malaysia by taking into account her varied needs. Even as we navigate through the COVID-19 pandemic, we have seen women rise to the occasion and put on the many hats she wears simultaneously – this is no easy feat and we want to do all that we can to support her and her health,” said Bilal Somra.
Women play an important role towards a healthier nation and world. And Organon is poised to support her journey to improve her health and well-being, through medicines and tailored solutions across a range of areas.
“With the rise in issues such as unwanted pregnancies, lack of understanding about the need for family planning, amidst high prevalence rates of obesity, high cholesterol, and hypertension affecting women in Malaysia, it is fitting to introduce Organon to help address these areas and provide women with an opportunity to be in control of her health,” Somra added.
Yesterday, the Organon executive leadership team rang the opening bell at the New York Stock Exchange (NYSE) to mark the first day of active trading. Recognizing the need to listen to and act on women’s experiences to address the challenges in women’s health, Organon gathered voices from around the world to create the “Wall of Voices,” a multimedia installation outside of the NYSE sharing powerful perspectives, voices and images.
“Women are equal partners in our community and our country – as mothers, daughters, sisters, but also as professionals, entrepreneurs and employees. Support them, and build a stronger healthier community and country,” said Professor Datin Paduka Dr Teo Soo Hwang, Chief Scientific Officer of Cancer Research Malaysia.
“Women are like diamonds – strong, resilient, beautiful and precious. We believe that all women around the world and in our beloved country, Malaysia must be given the utmost respect and necessary support in making sure they stay healthy physically and emotionally so that they can keep their family and the country in good health. We need to empower women to take charge of their health so that they realize the ‘me’ is just as important as the ‘you’,” said Professor Dr Jamiyah Hassan, Visiting Lecturer and Consultant, Department of Obstetrics and Gynaecology, Universiti Teknologi Mara (UiTM).
Women everywhere are invited to take the “microphone” to add their voice to the digital “Wall of Voices” at HereForHerHealth.com. These initiatives are aligned with Organon’s Her Day which marks the beginning of the brand’s commitment towards the mission of bettering women’s health for every woman, every day.
Women at the Center: Organon’s Approach to Innovation
Organon’s R&D philosophy is to build a business around patient needs, with the goal of identifying and advancing healthcare options for women that enable them to live their best lives every day.
“For too long, for too many common conditions, such as heavy, painful, and irregular menstrual bleeding, incontinence and menopause and many others, women have been told to accept and normalize these conditions as a part of life,” said Sandy Milligan, Head of Organon Research & Development. “Organon’s mission is to change this. We believe this approach will be very successful — the ability to identify diseases earlier, the ability to modify the course of diseases or healthcare conditions and to ultimately, improve the quality of life for women at all stages.”
The company’s extensive global capabilities in clinical development and patient safety, regulatory and medical affairs make it well-positioned to identify promising drugs, diagnostics and devices with the greatest potential to impact women’s health.
Learn more about Organon here.
You May Also Like
